BRCA testing and outcomes in women with breast cancer-Reference-Cited by-同舟云学术

BRCA testing and outcomes in women with breast cancer

Published:2021-01-03 Issue:3 Volume:186 Page:839-850
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Stenehjem David D.^ORCID,Telford Claire,Unni Sudhir K.,Bauer Hillevi,Sainski Amy,Deka Rishi,Schauerhamer Marisa B.,Ye Xiangyang,Tak Casey R.,Ma Junjie,Dalvi Tapashi B.,Gutierrez Lia,Kaye James A.,Tyczynski Jerzy E.,Brixner Diana I.,Biskupiak Joseph E.

Funder

AstraZeneca

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-020-06038-x.pdf

Reference33 articles.

1. O’Donovan PJ, Livingston DM (2010) BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair. Carcinogenesis 31:961–967. https://doi.org/10.1093/carcin/bgq069

2. Ford D, Easton DF, Peto J (1995) Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 57:1457–1462

3. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The breast cancer linkage consortium. Am J Hum Genet 62:676–689. https://doi.org/10.1086/301749

4. Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25:1329–1333. https://doi.org/10.1200/jco.2006.09.1066

5. Antoniou A, Pharoah PDP, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg Å, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjäkoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117–1130. https://doi.org/10.1086/375033

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low testing rates and high BRCA prevalence: Poly (ADP-ribose) polymerase inhibitor use in Middle East BRCA/homologous recombination deficiency-positive cancer patients;World Journal of Clinical Oncology;2024-07-24

2. Implementation of BRCA Test among Young Breast Cancer Patients in South Korea: A Nationwide Cohort Study;Cancer Research and Treatment;2024-07-15

3. Metastatic breast cancer with double heterozygosity for the BRCA1 and BRCA2 genes responding to olaparib: A case report;Oncology Letters;2024-04-09

4. BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients;BMC Medical Genomics;2024-01-02

5. Risks of non-ovarian cancers in women with borderline ovarian tumor: a national cohort study in Sweden;BMC Cancer;2023-10-09